Global vaccine egg supplier VALO BioMedia has upgraded its European Granja Rodriguez Serrano hatchery in Spain, with new setters from NatureForm Hatchery Technologies.
The 17-setter installation, a new for old replacement programme, was completed in a record two-week timescale by NatureForm Hatchery Technologies, avoiding any disruption to production in the vaccine hatchery.
“With extensive experience in the vaccines market, NatureForm totally understood the very specific requirements for this project,” says NatureForm CEO Steve Warren. “Within 14 days, all the existing machines were dismantled, floors were repaired, electro-mechanical works were completed and the new setters were installed, ready to resume incubation in line with Granja Rodriguez Serrano’s time-critical production schedule.”
Valo BioMedia is a global supplier of vaccine eggs, which are used to produce both human and animal vaccines, as well as for pharmaceutical research purposes. Alongside Spain, the company has facilities in Germany, Brasil, Mexico and North America, for a localised presence that is critical to working in partnership with its research and pharma clients worldwide.
“As a vaccine egg supplier, our production schedules are extremely time-sensitive. This refurbishment enabled us to continue meeting our current commitments, while also ensuring that Granja Rodriguez Serrano is primed and ready for future growth, as a result of increased demand for vaccine eggs in the market”, says Antonio Rodriguez Serrano, manager at Granja Rodriguez Serrano.
"*" indicates required fields
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (19) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.